Sanchez Ramiro
- SEC CIK
- 0001830326
No open-market purchases or sales filed in the past year.
Current role at each company
- RAPP Rapport Therapeutics, Inc.Directoras of Jun 10, 2026
- ANRO Alto Neuroscience, Inc.Directoras of May 14, 2026
- CERE Cerevel Therapeutics Holdings, Inc.Chief Medical Officeras of Aug 5, 2024
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Sanchez Ramiro as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
CERE Cerevel Therapeutics Holdings, Inc.
Chief Medical Officer4 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Dec 28, 2023 (view filing) | Dec 26 | 2 days | Sanchez RamiroChief Medical Officer | SSale | −10.0K | $42.47 | −$424.7K | −40.5%14.7K after | 10b5-1 |
| Dec 21, 2023 (view filing) | Dec 20 | 1 day | Sanchez RamiroChief Medical Officer | SSale | −10.2K | $41.42 | −$420.5K | −40.9%14.7K after | |
| Dec 19, 2023 (view filing) | Dec 15 | 4 days | Sanchez RamiroChief Medical Officer | SSale | −7.50K | $41.39 | −$310.4K | −100.0%0 after | |
| Dec 11, 2023 (view filing) | Dec 7 | 4 days | Sanchez RamiroChief Medical Officer | SSale | −10.0K | $41.37 | −$413.7K | −100.0%0 after | 10b5-1 |